Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
In: Antimicrobial Stewardship & Healthcare Epidemiology, Jg. 3 (2023)
Online
academicJournal
Zugriff:
COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies were common and approval by infectious disease physicians often required.
Titel: |
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
|
---|---|
Autor/in / Beteiligte Person: | Alfredo J. Mena Lora ; Burgos, Rodrigo ; Borgetti, Scott ; Chaisson, Lelia H. ; Bleasdale, Susan C. |
Link: | |
Zeitschrift: | Antimicrobial Stewardship & Healthcare Epidemiology, Jg. 3 (2023) |
Veröffentlichung: | Cambridge University Press, 2023 |
Medientyp: | academicJournal |
ISSN: | 2732-494X (print) |
DOI: | 10.1017/ash.2023.205 |
Schlagwort: |
|
Sonstiges: |
|